JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD

Clinical trial NCT07115706 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07115706
Sponsor: Jeil Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Erosive Gastroesophageal Reflux Disease

Start date: 2025-08-25
Primary completion: 2026-07-31
Enrollment: 7150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.